Prenatal supplementation meta-analysis
This article was originally published in The Tan Sheet
Prenatal supplementation with multimicronutrients is associated with a significantly reduced risk of low birth weight infants and with improved birth weight compared with iron-folic acid supplementation, according to a meta-analysis in the June 9 issue of the Canadian Medical Association Journal. However, researchers led by Prakesh S. Shah of the University of Toronto found no effect on the risk of preterm birth or small-for-gestational-age infants. The analysis involved a search of Medline, EMBASE, CINAHL and the Cochrane Library for relevant articles published up to December 2008
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.